SOW
SMMT icon

State of Wyoming’s Summit Therapeutics SMMT Stock Holding History

State of Wyoming’s Portfolio SMMT Stock Details SMMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$524K Buy
+35,973
New +$638K 0.05% 377
2026
Q1 		– Sell
-11,533
Closed -$202K – 2018
2025
Q4 		$202K Buy
+11,533
New +$217K 0.02% 966

Other funds holding SMMT

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

State of Wyoming's SMMT Position: Q2 2026 in Review

State of Wyoming opened a new position in Summit Therapeutics (SMMT) in Q2 2026: 35,973 shares worth $524K. The stake represents 0.05% of the portfolio and ranks #377 among its holdings. This is a return to the name: State of Wyoming previously reported a position in SMMT as recently as Q4 2025.

State of Wyoming first reported a position in SMMT in Q4 2025 and has held it in 2 quarters since. 242 funds tracked by Wall St. Rank hold SMMT as of Q2 2026.

  • State of Wyoming held 35,973 shares of Summit Therapeutics worth $524K as of Q2 2026.
  • Summit Therapeutics was a new State of Wyoming position in Q2 2026.
  • Summit Therapeutics made up 0.05% of State of Wyoming's portfolio in Q2 2026, its #377 holding.
  • State of Wyoming first reported a position in Summit Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • 242 funds tracked by Wall St. Rank held Summit Therapeutics as of Q2 2026.

Based on State of Wyoming's 13F filing for Q2 2026, filed 6 Aug 2026.